Catalyst
Slingshot members are tracking this event:
Clovis Oncology Announces Rociletinib New Drug Application Scheduled for Presentation at Upcoming FDA Oncologic Drugs Advisory Committee Meeting on April 12, 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CLVS | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 12, 2016
Occurred Source:
http://phx.corporate-ir.net/phoenix.zhtml?c=247187&p=irol-newsArticle_Print&ID=2156480
Related Projects
Related Keywords
Rociletinib, Nda, New Drug Application, Oncologic Drugs Advisory Committee, Egfr T790m Mutation, Tiger-x, Tiger-2 Clinical Trials
